Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J I Weitz

Showing results (1-10 of 136) with videos related to

Pageof 14
Sort By:
Annals of the New York Academy of Sciences|January 1, 1991
Development and application of assays for elastase-specific fibrinogen fragmentsJ I Weitz
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Factor Xa or thrombin: is thrombin a better target?J I Weitz
Coronary Artery Disease|June 1, 1996
Biological rationale for the therapeutic role of specific antithrombinsJ I Weitz
Journal of Thrombosis and Thrombolysis|November 17, 2001
New anticoagulant drugsJ I Weitz
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 5, 2001
Recruiting researchersJ I Weitz
Haemostasis|January 12, 2000
New antithrombotic drugs: beyond aspirin and heparinJ I Weitz
Thrombosis and Haemostasis|April 1, 1996
Elevated fibrinopeptide A and B levels during thrombolytic therapy: real or artefactual?J I Weitz
The American Journal of Cardiology|February 23, 1995
Activation of blood coagulation by plaque rupture: mechanisms and preventionJ I Weitz
Bailliere'S Clinical Haematology|July 1, 1990
Mechanism of action of the thrombolytic agentsJ I Weitz
Journal of Vascular and Interventional Radiology : JVIR|November 1, 1995
Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleedingJ I Weitz
Pageof 14

Showing results (1-10 of 136) with videos related to

Sort By:
Pageof 14
Annals of the New York Academy of Sciences|January 1, 1991
Development and application of assays for elastase-specific fibrinogen fragmentsJ I Weitz
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Factor Xa or thrombin: is thrombin a better target?J I Weitz
Coronary Artery Disease|June 1, 1996
Biological rationale for the therapeutic role of specific antithrombinsJ I Weitz
Journal of Thrombosis and Thrombolysis|November 17, 2001
New anticoagulant drugsJ I Weitz
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|July 5, 2001
Recruiting researchersJ I Weitz
Haemostasis|January 12, 2000
New antithrombotic drugs: beyond aspirin and heparinJ I Weitz
Thrombosis and Haemostasis|April 1, 1996
Elevated fibrinopeptide A and B levels during thrombolytic therapy: real or artefactual?J I Weitz
The American Journal of Cardiology|February 23, 1995
Activation of blood coagulation by plaque rupture: mechanisms and preventionJ I Weitz
Bailliere'S Clinical Haematology|July 1, 1990
Mechanism of action of the thrombolytic agentsJ I Weitz
Journal of Vascular and Interventional Radiology : JVIR|November 1, 1995
Limited fibrin specificity of tissue-type plasminogen activator and its potential link to bleedingJ I Weitz
Pageof 14